​

Avadel Pharmaceuticals (AVDL) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

AVDL Stock Forecast

Avadel Pharmaceuticals (AVDL) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $23.33, with a high of $30.00 and a low of $19.00. This represents a 204.57% increase from the last price of $7.66.

$5 $10 $15 $20 $25 $30 High: $30 Avg: $23.33 Low: $19 Last Closed Price: $7.66

AVDL Stock Rating

Avadel Pharmaceuticals stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 8 0 8 Strong Sell Sell Hold Buy Strong Buy

AVDL Forecast vs Benchmarks

TypeNameUpside
StockAvadel Pharmaceuticals204.57%
SectorHealthcare Stocks 25.20%
IndustrySpecialty & Generic Drug Manufacturers Stocks24.78%

Price Target Trends

1M3M12M
# Anlaysts234
Avg Price Target$20.00$23.33$24.25
Last Closing Price$7.66$7.66$7.66
Upside/Downside161.10%204.57%216.58%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 2537---10
Dec, 2437---10
Nov, 2437---10
Oct, 2447---11
Sep, 2447---11
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 10, 2025Oren LivnatH.C. Wainwright$21.00$7.90165.82%174.15%
Jan 09, 2025Ami FadiaNeedham$19.00$10.8674.95%148.04%
Oct 31, 2024Francois BriseboisOppenheimer$30.00$12.91132.38%291.64%
May 09, 2024Oren LivnatH.C. Wainwright$27.00$16.2566.15%252.48%
Nov 30, 2022Jefferies$11.00$8.8524.29%43.60%
Aug 11, 2022Leerink Partners$12.00$7.1468.07%56.66%
Aug 10, 2022Needham$9.00$7.3123.12%17.49%
Aug 09, 2022Chris HowertonJefferies$8.00$7.319.44%4.44%
May 31, 2022Needham$6.00$2.50140.00%-21.67%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Jan 10, 2025OppenheimerOutperformOutperformhold
Jan 10, 2025H.C. WainwrightBuyBuyhold
Jan 09, 2025NeedhamBuyBuyhold
Oct 31, 2024OppenheimerOutperformOutperformhold
Oct 21, 2024H.C. WainwrightBuyBuyhold
Aug 28, 2024H.C. WainwrightBuyBuyhold
Jun 11, 2024Rodman & RenshawBuyinitialise
May 09, 2024Craig-HallumBuyBuyhold
May 09, 2024H.C. WainwrightBuyBuyhold
Mar 05, 2024OppenheimerOutperformOutperformhold

Financial Forecast

EPS Forecast

Dec 20 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$0.13$-2.00-----
Avg Forecast$-0.13$-1.79$-0.50$0.15$0.76$1.45$1.87
High Forecast$-0.14$-1.83$-0.53$0.03$0.49$1.27$1.81
Low Forecast$-0.12$-1.76$-0.45$0.49$1.03$1.95$1.91
Surprise %-200.00%11.73%-----

Revenue Forecast

$0 $100M $200M $300M $400M $500M Dec 20 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$22.33M$27.96M-----
Avg Forecast$22.32M$26.75M$168.79M$252.17M$336.16M$406.73M$463.03M
High Forecast$20.96M$24.11M$168.73M$247.31M$334.19M$404.86M$451.77M
Low Forecast$23.95M$28.37M$169.03M$255.17M$338.14M$408.60M$469.81M
Surprise %0.08%4.55%-----

Net Income Forecast

$-200M $-120M $-40M $40M $120M $200M Dec 20 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$7.03M$-160.28M-----
Avg Forecast$-10.42M$-144.15M$-39.30M$11.63M$78.12M$149.10M$149.93M
High Forecast$-11.41M$-147.06M$-42.44M$2.19M$39.56M$101.92M$145.19M
Low Forecast$-9.60M$-141.24M$-36.16M$39.36M$82.27M$156.07M$152.78M
Surprise %-167.43%11.19%-----

AVDL Forecast FAQ

Is Avadel Pharmaceuticals stock a buy?

Avadel Pharmaceuticals stock has a consensus rating of Buy, based on 8 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Avadel Pharmaceuticals is a favorable investment for most analysts.

What is Avadel Pharmaceuticals's price target?

Avadel Pharmaceuticals's price target, set by 8 Wall Street analysts, averages $23.33 over the next 12 months. The price target range spans from $19 at the low end to $30 at the high end, suggesting a potential 204.57% change from the previous close price of $7.66.

How does Avadel Pharmaceuticals stock forecast compare to the average forecast of its sector, industry, and investment themes?

Avadel Pharmaceuticals stock forecast shows a 204.57% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the specialty & generic drug manufacturers stocks industry (24.78%).

What is the breakdown of analyst ratings for Avadel Pharmaceuticals over the past three months?

  • January 2025: 30.00% Strong Buy, 70.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 30.00% Strong Buy, 70.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 30.00% Strong Buy, 70.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Avadel Pharmaceuticals’s EPS forecast?

Avadel Pharmaceuticals's average annual EPS forecast for its fiscal year ending in December is -0.5 for 2024, a -75.00% decrease from the reported $-2 in 2023. The prediction for 2025 is $0.15, $0.76 for 2026, $1.45 for 2027, and $1.87 for 2028.

What is Avadel Pharmaceuticals’s revenue forecast?

Avadel Pharmaceuticals's average annual revenue forecast for its fiscal year ending in December is $168.79M for 2024, a 503.62% increase from the reported $27.96M in 2023. The forecast for 2025 is $252.17M, $336.16M for 2026, $406.73M for 2027, and $463.03M for 2028.

What is Avadel Pharmaceuticals’s net income forecast?

For its fiscal year ending in December, Avadel Pharmaceuticals's average annual net income forecast is $-39.301M for 2024, reflecting a -75.48% decrease from the reported $-160M in 2023. The projection for 2025 is $11.64M, $78.12M for 2026, $149.1M for 2027, and $149.93M for 2028.